Verve Medical

Phoenix, AZ · Founded 2010 · Privately Held (backing)

Developer of renal denervation devices intended to reduce hypertension. Verve Medical is based in Phoenix, AZ and was founded in 2010. It was valued at $64 million at its later-stage round in Aug 2020, the last priced event on record. It has raised $11.2 million across 2 recorded rounds; the latest was a $470,000 seed round in Oct 2016.

PMV mark · valuation
$64.0M
Oct 2026
Priced at
its later-stage round
Aug 2020
Total raised
$11.2M
Last round
Seed Round
Oct 2016

Verve Medical key facts

as of Oct 2026
  • Developer of renal denervation devices intended to reduce hypertension.
  • Verve Medical is valued at approximately $64.0M as of Oct 2026, set at its later-stage round, Aug 2020; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $11.2M across 2 recorded rounds; the latest was Seed Round ($470K) in Oct 2016.
  • Notable investors include Flinn Foundation, BioAccel, HM Venture Partners, LongRiver Investments.
  • Verve Medical has filed 3 Form Ds with the SEC since 2015, most recently Jan 2017 ($470K sold to 5 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$64.0M

Valued at $64.0M at its later-stage round, Aug 2020. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Verve Medical with a free account
  • ·Watch Verve Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Verve Medical funding rounds

2 rounds
Oct 2016Seed Round$470KSEC filing▮
Dec 2014Seed Round$1.9MSEC filing▮

Verve Medical valuation

Verve Medical was valued at $64 million at its later-stage round in Aug 2020. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Verve Medical raised?

Verve Medical has raised $11.2 million in total; 2 of its rounds are on record. The largest on record was a $470,000 seed round in Oct 2016.

Verve Medical has filed 3 Form Ds with the SEC since 2015, most recently in Jan 2017 ($470,000 sold to 5 investors).

Verve Medical investors

4 investors are on record for Verve Medical, including Flinn Foundation, BioAccel, HM Venture Partners and LongRiver Investments. The seed round in Oct 2016 drew 5 investors.

About Verve Medical

Developer of renal denervation devices intended to reduce hypertension. The company's devices reduce systolic blood pressure for treating hypertension by reducing the sympathetic nervous system drive through renal denervation, enabling patients to reduce the risk related to stroke and heart disease.

Sector
Healthcare
HQ
Phoenix, AZ, United States
Founded
2010
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.